GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » Profitability Rank

MMNFQ (MedMen Enterprises) Profitability Rank : 0 (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Profitability Rank?

MedMen Enterprises has the Profitability Rank of 0.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

MedMen Enterprises's Operating Margin % for the quarter that ended in Mar. 2023 was -37.73%. As of today, MedMen Enterprises's Piotroski F-Score is 0.


Competitive Comparison of MedMen Enterprises's Profitability Rank

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's Profitability Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Profitability Rank distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Profitability Rank falls into.



MedMen Enterprises Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

MedMen Enterprises has the Profitability Rank of 0.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

MedMen Enterprises's Operating Margin % for the quarter that ended in Mar. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2023 ) / Revenue (Q: Mar. 2023 )
=-10.273 / 27.225
=-37.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

MedMen Enterprises has an F-score of 0. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


MedMen Enterprises Profitability Rank Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises Business Description

Traded in Other Exchanges
N/A
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.